Andrew Osborne

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 5

Top Topics

Mesenchymal Stem Cells

African American

Diabetic Retinopathy

Gene Expression

Top Venues

Stem cells (Dayton, Ohio)

Methods in molecular biology (Clifton, N.J.)

This page only lists publications with an associated author ORCID identifier.

Publications

Bart Nieuwenhuis, Elise Laperrousaz, James R Tribble, Joost Verhaagen, James W Fawcett, Keith R Martin, Pete A Williams, Andrew Osborne
Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters. Gene therapy (2023)
Bart Nieuwenhuis, Elise Laperrousaz, James R Tribble, Joost Verhaagen, James W Fawcett, Keith R Martin, Pete A Williams, Andrew Osborne
Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters. Gene therapy (2023)
Bart Nieuwenhuis, Elise Laperrousaz, James R Tribble, Joost Verhaagen, James W Fawcett, Keith R Martin, Pete A Williams, Andrew Osborne
Improving adeno-associated viral (AAV) vector-mediated transgene expression in retinal ganglion cells: comparison of five promoters. Gene therapy (2023)
Bart Nieuwenhuis, Andrew Osborne
Intravitreal Injection of AAV for the Transduction of Mouse Retinal Ganglion Cells. Methods in molecular biology (Clifton, N.J.) 2708 (2023)
Andrew Osborne, Julie Sanderson, Keith R Martin
Neuroprotective Effects of Human Mesenchymal Stem Cells and Platelet-Derived Growth Factor on Human Retinal Ganglion Cells. Stem cells (Dayton, Ohio) 36 (1) (2017)